15 July 2024 · Informing and supporting decision making when considering the most appropriate legal mechanism for administering contrast agents in imaging services.
16 December 2016 · Variation in practice underlined the need for an evidence-based guideline for handling mAbs that was suited to all those providing care to NHS patients.
12 April 2019 · In March 2018 NHMC approved a list of standard service areas which will be incorporated into version 6 of the national KPI dataset. Homecare providers…
4 June 2021 · The stability of several aseptically compounded ready to administer presentations of monoclonal antibody products and other biopharmaceuticals is presented.
2 October 2018 · This document outlines key areas where Chief Pharmacists should focus pharmaceutical expertise prior to an organisation implementing CAR-T Therapy.
16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.
16 November 2021 · A single Patient Group Direction (PGD) can be used to supply or administer medicines in more than one location. PGDs do not need to relate to specific premises.
5 March 2024 · One licensed tocilizumab biosimilar is available: Tyenne. Learn about the licensed indications, supporting evidence and key differences.